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Abstract
Background:  The rehabilitation of knee osteoarthritis often includes electrotherapeutic
modalities as well as advice and exercise. One commonly used modality is pulsed electromagnetic
field therapy (PEMF). PEMF uses electro magnetically generated fields to promote tissue repair and
healing rates. Its equivocal benefit over placebo treatment has been previously suggested however
recently a number of randomised controlled trials have been published that have allowed a
systematic review to be conducted.
Methods: A systematic review of the literature from 1966 to 2005 was undertaken. Relevant
computerised bibliographic databases were searched and papers reviewed independently by two
reviewers for quality using validated criteria for assessment. The key outcomes of pain and
functional disability were analysed with weighted and standardised mean differences being
calculated.
Results: Five randomised controlled trials comparing PEMF with placebo were identified. The
weighted mean differences of the five papers for improvement in pain and function, were small and
their 95% confidence intervals included the null.
Conclusion: This systematic review provides further evidence that PEMF has little value in the
management of knee osteoarthritis. There appears to be clear evidence for the recommendation
that PEMF does not significantly reduce the pain of knee osteoarthritis.
Background
Osteoarthritis is a major health problem affecting over
60% of adults in the Western world over 65 years of age,
yet it receives scant resources for treatment or clinical
research [1,2]. The knee is one of the most commonly
affected joints and patients present with a combination of
pain, deformity, inflammation, stiffness and muscle atro-
phy. With the lack of cure, none surgical treatment is usu-
ally directed to symptomatic relief and prevention of
functional dysfunctio [3]. One such treatment modality is
pulsed electromagnetic field therapy, that uses electro-
magnetic fields with an on-off effect of pulsing to produce
athermal effects that promote tissue healing and relieve
pain and inflammation [4]. Despite the lack of knowledge
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of its effects over placebo, this modality has increased in
use significantly over the last 25 years [4].
There has been some analysis of the data regarding the
effectiveness of pulsed electromagnetic fields (PEMF) with
knee osteoarthritis patients. Marks et al [3] published a lit-
erature review on the effects on knee osteoarthritis of both
pulsed and continuous shortwave diathermy. The equivo-
cal results of this review were attributed, in part, to the
poor methodological quality of the 11 non-randomised
comparative and randomised controlled trials (RCTs)
they studied. Hulme et al. [5] published a Cochrane
review, in 2001. They identified only 3 papers, of ade-
quate quality for review, totalling 259 patients, and con-
cluded there was a lack of evidence of a clinically
important effect of PEMF in the treatment of knee osteoar-
thritis.
We have become aware of several prospective randomised
controlled trials comparing PEMF to placebo PEMF, in the
treatment of knee osteoarthritis. Thus, we undertook a
systematic review of the studies published in the last 10
years to specifically evaluate PEMF for patients with knee
osteoarthritis.
Methods
We performed a similar search strategy to that used by
Hulme et al 2001 [5] with the following criteria for inclu-
sion in the review.
Types of studies
1. Randomised controlled trials
2. Controlled clinical trials
Trials were not included if they measured bone and carti-
lage repair from electromagnetic therapy following a spe-
cific treatment for osteoarthritis, which would then no
longer be applicable to all knee OA patients.
Types of participants
Those trials with subjects over 18 years of age, with clini-
cal and radiological confirmation of the diagnosis were
considered.
Types of intervention
All types of PEMF and Pulsed Electrical Stimulation trials
were included. Although the latter relies on direct applica-
tion of an electrical field rather than creating induced cur-
rent through magnetic impulses, they act by the same
mechanism. Trials that compared the intervention group
using PEMF to a standard treatment were included, as well
as placebo-controlled studies.
Outcomes
The main outcomes of interest were pain and functional
disability as recorded by validated self report instruments
such as the Western Ontario and McMasters University
Osteoarthritis Index WOMAC [6], EuroQol [7], Arthritis
Impact Measurement Scale AIMS[8] or SF-36 [9]. Studies
that did not utilise validated outcome measures of pain
and function were excluded.
We searched MEDLINE, AMED, EMBASE, HealthSTAR,
CINAHL, PEDro, and SPORTDiscus and the Cochrane
Controlled Trials Register (CCTR) from January 1966 to
September 2005. The electronic search was comple-
mented by the following hand searches of bibliographic
references and abstracts published in special issues of spe-
cialized journals or in Conference Proceedings. Reference
lists were hand-search for further identification of pub-
lished work, presentations at scientific meetings and per-
sonal communications. Abstracts were not used if
additional data could not be obtained. The publication
bias could not be assessed due to the small number of
included studies.
Search strategy
1 exp osteoarthritis/or osteoarthritis.tw.
2 electromagnetics.mp. or electromagnetic fields/[mp =
title, abstract, registry number word, mesh subject head-
ing]
3 electromagnetic$.tw.
4 exp electric stimulation therapy/
5 electrical stimulation.tw.
6 or/2–5
7 1 and 6
Assessing quality
Abstracts were read to make the final decision on selection
of the full paper for review. The quality of the papers was
assessed by two reviewers independently using a validated
criteria checklist[10]. The maximum total score achieva-
ble was 5. Any differences were resolved by discussion
between the reviewers. Differences unresolved in this
manner were resolved in discussion with a third reviewer.
Statistical analysis
For pain and functional outcomes, weighted mean differ-
ences and standardised mean differences, with 95% con-
fidence intervals, were calculated. Due to differences in
follow up assessment timings, data were analysed from
the immediate post-intervention assessments. A priori itBMC Musculoskeletal Disorders 2006, 7:51 http://www.biomedcentral.com/1471-2474/7/51
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was decided that an effect size difference in post treatment
scores of greater than 0.2 was required to represent a clin-
ically important difference. Effect sizes were calculated by
dividing the difference in post-treatment group mean
scores by the pooled standard deviation of both baseline
scores.
Results
The literature searches produced 20 randomised control-
led trials and 5 non randomised clinical trials. Abstracts
were viewed to exclude duplicate publications, narrative
reviews, letters, commentaries, use of electrical stimula-
tion that was not PEMF, pathologies other than knee oste-
oarthritis and non-randomised trials. Three studies,
reported in previous systematic reviews were excluded due
to their use of non-validated outcome measures [11-13].
As a result, five papers were found that met the review
selection criteria. These were all RCTs with placebo con-
trolled PEMF. All these trials used both a pain scale and a
measure of self reported functional status. The five trials
provided data for a total of 276 patients with knee oste-
oarthritis.
Two studies used low frequency PEMF ranging from 3 to
50 Hz requiring long durations of treatment (3 to 10
hours a week) [14,15] whilst three studies used typical
"pulsed short wave", high frequency devices with shorter
treatment durations [16-18]. The low frequency, long
duration treatments showed a greater trend for short-term
improvement in WOMAC function score than the high
frequency, low duration treatments but an equivocal lack
of benefit in pain relief.
The highest score for study quality was 5/5 [19] with the
lowest being 3/5 [15]. See Table 1. The weighted mean dif-
ferences for improvement in pain and function were
extremely small and well below the levels one might con-
sider clinically significant. The weighted mean confidence
intervals included the null value, for both outcomes, pain
0.66 (95%CI 0.35 to -1.67), function 0.70 (0.52 to -1.92)
See Figure 1. Effect sizes were not statistically or clinically
significant for all outcomes with the exception of function
in one study, with a low quality score (3/5), (effect size for
Function 0.59, 95%CI 0.14 to 1.12) [15].
Discussion
It is unusual for a rehabilitation electrotherapeutic modal-
ity to be evaluated in a series of RCTs and thus to find a
number of randomised controlled trials of intervention
versus control was encouraging. The findings of this
review support and update the work of previous reviewers
[5]. Despite relatively low total patient numbers (n = 276)
and some heterogeneity in the frequency of the PEMF
used, it would appear that PEMF has little clinical value in
reducing the pain of knee osteoarthritis. The assertion that
PEMF has no clinically significant benefit, above that
Table 1: A table showing the methodological score, numbers, duration of treatment, outcomes measures and standardised mean 
difference for pain and function
Author Quality 
Score[10] (0–
5)
Number 
receiving 
PEMF
Number 
receiving 
placebo
Duration of 
Treatment 
(weeks)
Pain 
Outcome
Functional 
Outcome
Standardised 
Mean 
Difference for 
pain (95%CI)
Standardised 
Mean 
Difference for 
function 
(95%CI)
Klaber-
Moffett et al 
1996[16]
5 26 22 3 VAS Pain 
Scale
None 
reported
-0.03 (-0.59 
to 0.54)
None 
reported
Pipetone et al 
2001[14]
5 34 35 6 WOMAC 
Pain Scale
WOMAC 
Physical 
Function 
Scale
-0.10 (-0.58 
to 0.37)
-0.33 (-0.80 
to 0.15)
Thamsborg et 
al 2005[15]
3 42 41 6 WOMAC 
Pain scale
WOMAC 
Physical 
Function 
Scale
-0.31 (-0.74 
to 0.12)
-0.58 (-1.02 
to -0.14)
Laufer et al 
2005[17]
3 27 31 3 WOMAC 
Pain scale
WOMAC 
Physical 
Function 
Scale
-0.05 (-0.57 
to 0.46)
-0.09 (-0.60 
to 0.43)
Callaghan et 
al 2005[18]
4992 V A S  P a i n  
Scale
AIMS -0.33 (-1.26 
to 0.61)
0.00 (-0.92 to 
0.92)
TOTAL 138 138 -0.16 (-0.39 
to 0.08)
-0.33 (-0.59 
to -0.07)
VAS – Visual analogue scale,
WOMAC – Western Ontario and McMaster's Universities OA index
AIMS – Arthritis Impact Measurement ScaleBMC Musculoskeletal Disorders 2006, 7:51 http://www.biomedcentral.com/1471-2474/7/51
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achieved with placebo treatment, on the pain of patients
with knee osteoarthritis can be confidently proposed. An
improvement in WOMAC physical function score was
described by one study, however this study had a low
methodological score and used a unique PEMF device,
unreplicated by other studies. The same study did not
report an improvement in pain [15].
Conclusion
Current evidence would suggest that PEMF is unlikely to
be a valuable contributor to multimodal rehabilitation of
knee osteoarthritis. The resources currently being used for
the provision of PEMF may be better utilised in the
deployment of more clinically efficacious rehabilitation,
such as in the provision of exercise classes and advice ses-
sions [20, 21].
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